A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

NCT00753415 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Carcinoma
Breast Cancer
Melanoma
Upper GI Tract Carcinoma
Colon Carcinoma
Renal Cell Carcinoma
Bladder Carcinoma
Prostate Cancer

Interventions

BIOLOGICAL: V935
BIOLOGICAL: V934-EP

Sponsor

Merck Sharp & Dohme LLC